Beta-Lactam and Sulfonamide Allergy Testing Should Be a Standard of Care in Immunocompromised Hosts.

Trubiano JA, Slavin MA, Thursky KA, Grayson ML, Phillips EJ
J Allergy Clin Immunol Pract. 2019 7 (7): 2151-2153

PMID: 31253580 · PMCID: PMC6733665 · DOI:10.1016/j.jaip.2019.05.051

Antibiotic allergies are reported in up to 1 in 4 immunocompromised hosts with significant impacts on antibiotic utilization and patient outcomes. Health services programs focused on de-labeling beta-lactam and sulfonamide allergy labels should be a standard of care in immunocompromised hosts.

Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

MeSH Terms (11)

Anti-Bacterial Agents beta-Lactams Chemoprevention Drug Hypersensitivity Humans Immunocompromised Host Penicillins Self Report Skin Tests Sulfonamides Trimethoprim, Sulfamethoxazole Drug Combination

Connections (1)

This publication is referenced by other Labnodes entities: